Dxcover
Glasgow · Founded 2016
About Dxcover
Dxcover is a clinical-stage liquid biopsy firm that is developing diagnostics for the early diagnosis of numerous malignancies, when treatment has a better possibility of having an influence on outcomes. The business was the first to use infrared spectroscopy of circulating pan-omic indicators to detect and identify cancer. The business has generated compelling clinical data on the diagnosis of Stage I and Stage II malignancies with high accuracy. Dxcover was established in 2016 in Glasgow, Glasgow City by David S Palmer, Holly Butler, and Matthew Baker.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $24.4M
- Last round: Series Unknown (Feb 2025)
- Website: http://www.dxcover.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Machine Learning, Medical
Social Profiles
Canonical: https://fsome.com/organization/dxcover-38973 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.